Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. (Q41823201)
Jump to navigation
Jump to search
scientific article published on 19 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. |
scientific article published on 19 April 2016 |
Statements
1 reference
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. (English)
1 reference
Robert Provenzano
1 reference
Anatole Besarab
1 reference
Chao H Sun
1 reference
Susan A Diamond
1 reference
John H Durham
1 reference
Jose L Cangiano
1 reference
Joseph R Aiello
1 reference
James E Novak
1 reference
Tyson Lee
1 reference
Robert Leong
1 reference
Brian K Roberts
1 reference
Khalil G Saikali
1 reference
Stefan Hemmerich
1 reference
Lynda A Szczech
1 reference
Kin-Hung Peony Yu
1 reference
Thomas B Neff
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference